Retractable Technologies price to free cash flow RVP
Market value divided by free cash flow over the last twelve months, since 2012.
- Today, Oct 23, 2026
- n/m
- not a meaningful number
- Last meaningful
- 5.1×
- Nov 2024
- 7-year median
- 26.1×
- 7-year range
- 4.4× to 388×
- Peer median
- 9.2×
Retractable Technologies' price to free cash flow is not a meaningful number today: free cash flow over the last twelve months was zero, negative or not reported.
It was last meaningful in Nov 2024, at 5.1×.
On the days it had one over the last 7 years, its median was 26.1×, from 4.4× in Nov 2023 to 388× in Feb 2020.
Price to free cash flow over time
The dashed line is the 7-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2024 | 5.1× | 4.6× | 17.1× |
| 2023 | 4.5× | 4.4× | 4.6× |
| 2022 | n/m a value too high to mean anything | ||
| 2021 | n/m a value too high to mean anything | ||
| 2020 | 106× | 26.1× | 388× |
| 2019 | 328× | 295× | 328× |
| 2018 | n/m a value too high to mean anything | ||
| 2017 | n/m a value too high to mean anything | ||
| 2016 | n/m a value too high to mean anything | ||
| 2015 | n/m a value too high to mean anything | ||
| 2014 | 27.2× | 22.2× | 57.3× |
| 2013 | 20.8× | 18.4× | 20.8× |
| 2012 | 8.8× | 7.2× | 9.0× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Retractable Technologies' size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| RVPRetractable Technologies | n/m |
| NEPHNephros | n/m |
| APTAlpha Pro Tech | 9.7× |
| KEQUKewaunee Scientific | 8.7× |
| Peer median | 9.2× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Retractable Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.